logo
Illness Took My Mother's Independence, but It Gave Us Something Precious

Illness Took My Mother's Independence, but It Gave Us Something Precious

New York Times21 hours ago
On a breezy evening in the year 2000, Mom walked barefoot out to the freezer in her garage, as a fourth-generation Californian is wont to do. But as she dug through the cave of icy corn dogs and Costco salmon, she was distracted by a startling sensation: Her right foot was cold atop the wind-chilled pavement, but her left foot was burning hot.
Multiple sclerosis is best described as a disease of self-sabotage. As the body eats away at its nerves' protective exterior, the nervous system loses its ability to fire, leading over time to various debilitations. For Mom, this meant losing control of the left side of her body. Over the course of five years, she went from walking with a cane to supporting herself with her service dog's harness to eventually using a walker. If you were to map the development of her disability, it might look like Rudolph Zallinger's illustration of human evolution in reverse: beginning upright on two feet but then morphing into a hunched-over figure, arms hanging like pendulums.
My mom's transformation was hard for me to accept. I was a moody teen, more concerned with my high school microdramas than with my mother's ailments. I blamed her for everything that went wrong in my life, without ever really considering how she might be privately struggling. The one tradition we did share was our trips to the mall, where we tried on clothes and ate our favorite Cobb salads. But eventually even those visits dwindled. In college, I finally realized that my mother could no longer trawl through the shoe aisle.
Years later, living in New York, I saw a retrospective at the Met of the artist Alice Neel and was moved by a nude self-portrait she painted as an older woman, in which she sits in a striped armchair. There was so much dignity and defiance in her eyes, despite the sagging skin below them. A month later, when my parents visited, I knew I had to share what I had seen with my mom. Canes and handicap placards made Mom feel, and look, older than she was, but Neel demonstrated how aging could be beautiful and enchanting. And while museum-supplied wheelchairs were a few sizes too big for my mom's tiny frame, I knew she would enjoy visiting as much as I would. Hours passed quickly as I pushed her around the exhibit, moving toward the portrait of Neel.
By this point, my mom had reluctantly accepted that riding in a wheelchair was the quickest way to navigate an airport terminal, and she had already bickered with a friend about whether she needed help getting around a London rose garden. But there is something different, for me, about pushing my mom around a museum, whispering in her ear as if she were a baby in a stroller; I'm more responsible for her now than she is for me. Looking at art from a wheelchair might have begun as a painful development for my mother, but it has since blossomed into something alive and serendipitous, one of the best remaining activities we can share together — and, somewhat surprisingly, a lesson about how to actually start seeing.
There are studies that show that people look at a piece of art in a museum for an average of just 27 seconds; students of art history may be familiar with John Berger's idea that visitors are overwhelmed by 'their own culpable inability to concentrate on more than a few of these works,' and so they can't distinguish the good from the bad. But seeing art with a disabled person requires a more thoughtful, more patient and — most important — slower approach.
Want all of The Times? Subscribe.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A Simple Change To Your Evening Routine Could Help You Exercise More
A Simple Change To Your Evening Routine Could Help You Exercise More

Yahoo

timean hour ago

  • Yahoo

A Simple Change To Your Evening Routine Could Help You Exercise More

If you're determined to log more minutes of exercise tomorrow, going to bed earlier tonight could help, according to a new study that analyzed the relationship between bedtimes and subsequent physical activity levels. The study was led by researchers from Monash University in Australia, and while it doesn't definitively prove that heading to bed early means you're likely to exercise more the next day, it suggests there's a significant connection. And the sheer amount of data collected for the study supports that connection: data from wearables for 19,963 people was logged over the course of a year, giving the researchers information on almost six million night-and-day reference points. "These insights carry meaningful implications for public health," says psychologist Josh Leota, from Monash University. Related: "Rather than just promoting sleep and physical activity independently, health campaigns could encourage earlier bedtimes to naturally foster more active lifestyles." Overall, an earlier bedtime matched up with more moderate-to-vigorous exercise the next day, the data showed. Those who went to bed at 9pm logged an average of 30 minutes more than those who went to bed at 1am, for example, and 15 minutes more than those with an 11pm bedtime (the average bedtime across all participants). The amount of sleep mattered too: those who banked an average of 5 hours logged 41.5 more minutes of exercise compared to those who banked an average of 9 hours (though the benefits of exercise may be counterbalanced by the effects of sleep deprivation). Another key finding was that when individuals went to bed earlier than normal, but still banked the same amount of sleep that they usually did, they tended to hit their personal bests in terms of activity time the next day. There are a few reasons why this might be happening, the researchers suggest. Later bedtimes may indicate people who are busier in general, and might also mean there's less of a likelihood to lie in or hit the snooze button the next day – though wake-up times weren't included in the study data. "Standard 9-to-5 routines can clash with the natural sleep preferences of evening types, leading to social jetlag, poorer sleep quality, and increased daytime sleepiness – which can all reduce motivation and opportunity for physical activity the next day," says Leota. Factors controlled for in the study included age, body mass index, and whether it was a weekday or weekend. The researchers also found a similar but less prominent relationship in a second, more diverse set of data from 5,898 people, backing up the initial results. As this study is based on a correlation, it may still be that other factors, like naturally being a 'night owl', is contributing to both the late sleep and lower exercise times. Until more research can pry such other variables apart, it's not possible to draw firm conclusions. However, we know both sleep and exercise are fundamental parts of living a healthy life, and the study points to a simple intervention many of us could consider to boost our well-being: moving our bedtimes forward a little bit. "Sleep and physical activity are both critical to health, but until now we didn't fully grasp how intricately connected they are in everyday life," says psychologist Elise Facer-Childs, from Monash University. "Our findings are consistent across different populations, and show that if you can get to sleep earlier than usual whilst keeping your sleep duration the same, you may be more likely to increase your physical activity the following day." The research has been published in PNAS. 'Sky-High' Levels of Alzheimer's Protein Found in Newborns Alzheimer's Might Not Actually Be a Brain Disease, Says Expert Bold Plan to DNA Test All Babies in UK Poses Serious Risks, Experts Warn

Ozempic Alternative Ditches The Needle And One Major Side Effect
Ozempic Alternative Ditches The Needle And One Major Side Effect

Yahoo

timean hour ago

  • Yahoo

Ozempic Alternative Ditches The Needle And One Major Side Effect

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to a new study. Although its efficacy hasn't yet been tested in humans, the compound could bypass some of the harmful side-effects associated with similar drugs. Unlike the famous family of GLP-1 receptor agonist drugs, this new candidate targets the β2-adrenergic receptor (β2AR). Drugs that do this aren't new: salbutamol (sold as Ventolin among other brand names) is widely prescribed for use in short stints to treat asthma and chronic obstructive pulmonary disease. Clenbuterol is also prescribed for asthma in some countries, though it's better known as a performance-enhancing drug, banned by the World Anti-Doping Agency for its anabolic effects. For more than a decade, scientists have been trying to find a way to harness the benefits of β2AR agonists, without setting off their harmful effects. They can stimulate skeletal muscle glucose uptake and burn fat, mimicking the effects of exercise – but they have been considered too risky for treating diabetes or obesity, because of their tendency to wreak havoc on the heart. Related: The body's β2-adrenergic receptors are coupled with G proteins, and when activated for long periods (by β2AR drugs, for instance), the G proteins set off a chain reaction which leads to cardiovascular problems. "That would lead to heart rate increases, systolic blood pressure increases, and, eventually, that over-sustained exposure would lead to increases in heart weight and cardiac hypertrophy," molecular biologist Shane Wright, from Karolinska Institute in Sweden, told Mar de Miguel of Bioworld. But a campaign led by scientists from the Karolinska Institute, Stockholm University, and the biotech company Atrogi AB has revealed a series of β2AR agonist molecules that can side-step the slippery slope triggered by the G proteins. By activating only specific pathways, one of these – dubbed 'compound 15' – seems less likely to cause those concerning side effects, though we won't know for sure until further clinical trials are carried out. Unlike GLP-1 receptor agonists like Ozempic, compound 15 doesn't suppress appetite or lead to muscle loss, which means it may be safer in that regard too. It's also much more user-friendly, as a drug that can be swallowed rather than injected. "The goal was to try to target this other action that this receptor has expressed in the skeletal muscle, not in the heart, where it is mediating glucose uptake as a very beneficial outlet for lowering blood glucose levels," Wright said. So far, the newly-designed drug has been tested in lab-grown cells, male mice, rats, beagles, and phase 1 clinical trials (which only test for safety, not efficacy) in healthy and type 2 diabetic men. "Lead candidates of the chemical series increased glucose tolerance in preclinical models of diabetes and obesity with little or no increase in contractile force, cardiac lesions, and cardiac hypertrophy," the authors report. They also reversed muscle atrophy induced by GLP-1 drugs. "Clinical evaluation demonstrated that our lead candidate was orally bioavailable and safe in both healthy volunteers and type 2 diabetics, underlining its therapeutic potential." Many more tests – and a catchier name – will be needed before compound 15 or its relatives are made available as an alternative to GLP-1 drugs. Phase 2 clinical trials are underway to see if the enhanced muscle growth, balanced glucose levels, and insulin sensitivity seen in animal tests hold up in human bodies. "A well-tolerated GRK2-biased agonist offers significant therapeutic potential beyond type 2 diabetes and obesity… like muscular dystrophy and sarcopenia," the authors add. The research was published in Cell. A Simple Change To Your Evening Routine Could Help You Exercise More 'Sky-High' Levels of Alzheimer's Protein Found in Newborns Alzheimer's Might Not Actually Be a Brain Disease, Says Expert

There's a Critical Thing We Can All Do to Hold Alzheimer's Symptoms at Bay
There's a Critical Thing We Can All Do to Hold Alzheimer's Symptoms at Bay

Yahoo

timean hour ago

  • Yahoo

There's a Critical Thing We Can All Do to Hold Alzheimer's Symptoms at Bay

Deep sleep could forestall the declines in brain health that can eventually lead to Alzheimer's disease, the most common form of dementia. In their study of 62 older, cognitively healthy adults, researchers from the University of California (UC) Berkeley, Stanford University, and UC Irvine in the US found individuals with brain changes associated with Alzheimer's performed better on memory function tests as they got more deep sleep. This was irrespective of education and physical activity, two factors along with social connection known to contribute to cognitive resilience in older age. Those with similar Alzheimer's-linked changes who failed to get as much deep sleep didn't fare quite as well on the same tests. By comparison, sleep made little difference to those individuals with few deposits. Taken together, the results, which were published in May 2023, imply having a generous amount of solid shut-eye could help support the decline in memory that sets in as dementia begins to take hold. Watch the following video for a summary of the study: "Think of deep sleep almost like a life raft that keeps memory afloat, rather than memory getting dragged down by the weight of Alzheimer's disease pathology," said University of California (UC) Berkeley neuroscientist Matthew Walker. "This is especially exciting because we can do something about it. There are ways we can improve sleep, even in older adults." The study echoes previous research which has found a build-up of amyloid-beta proteins in the brains of people with disrupted sleep. But poor sleep is both a risk factor for and a symptom of Alzheimer's disease, making it tricky to tease apart cause and effect. Likewise, clumpy amyloid-beta proteins might only be a sign of Alzheimer's disease, not its root cause. Related: Even so, levels of amyloid-beta proteins are commonly used as a marker of Alzheimer's disease, as research suggests they – and another protein called tau – can start clogging up brain cells decades before symptoms of the disease arise. Past research from Walker's group found significant levels of amyloid-beta aggregating in the brains of older adults can disrupt deep sleep – also known as non-rapid eye movement slow wave sleep – and impair memory function. But some folk appear to stave off the decline that comes with Alzheimer's disease, even when levels of amyloid-beta proteins are relatively high. To find out why, Walker and colleagues monitored participants' brain waves as they slept, and then asked them to complete a memory test the next day. Among those whose brain scans revealed similarly high levels of beta-amyloid deposits, getting a good night's sleep seemed to make a critical difference in cognitive function. This effect was only seen when the researchers looked specifically at non-rapid eye movement slow wave sleep, and not at other sleep wave frequencies or sleep stages. Longer-term studies in older adults are needed to test whether increasing deep sleep over a number of years can actually help preserve a person's cognitive function in that time, even as levels of amyloid-beta increase. This research adds to scores of studies suggesting that sleep could be a modifiable risk factor for Alzheimer's disease, one that could potentially forestall molecular changes by giving the brain time to clean up waste products that accumulate during the day. It also points to sleep quality being important. "With a certain level of brain pathology, you're not destined for cognitive symptoms or memory issues," UC Berkeley neuroscientist and lead author Zsófia Zavecz said of the study findings in 2023. Although people may display molecular changes indicating a progression toward Alzheimer's disease, Zavecz says their findings suggest lifestyle factors can help buffer against those effects. "One of those factors is sleep and, specifically, deep sleep," she said. The study, though small, also hints at why getting good sleep naturally might be a better option than taking sleeping pills to get some shut-eye. Other research shows users of sleeping pills appear to have lower levels of amyloid proteins in their cerebrospinal fluid, which washes the brain clean at night. But these medications come with side effects; they may also lull people into shallow bouts of sleep rather than deep sleep phases. Instead, to set yourself up for a good night's sleep, Zavecz suggests cutting out coffee late in the day, doing some exercise, avoiding screen time, and taking a hot shower before bed. While you snooze, rest assured scientists are working hard to figure out the knotty problems of Alzheimer's disease, which affects millions of people worldwide. The study has been published in BMC Medicine. A version of this article was first published in May 2023. Ozempic Alternative Ditches The Needle And One Major Side Effect A Simple Change To Your Evening Routine Could Help You Exercise More 'Sky-High' Levels of Alzheimer's Protein Found in Newborns

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store